Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
Use this FHTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FHTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FHTX SEC filings page. Lician reads the product cache first so this HTML stays unique to Foghorn Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full FHTX income, balance, and cash tables.